However, little changes in the amount of BimEL and Bcl-2 (both non-phosphorylated and phosphorylated proteins) between AD individuals and control subjects indicate that Bax could become the major downstream target of p38K in this in vivo study of AD specimens. The gene discussed is BCL2; the disease is Alzheimer disease.